Diabetes Research and Clinical Practice
Volume 74 , Pages S116-S118 , December 2006

CSII in type 2 diabetic patients

  • Jean-Raymond Attali

      Affiliations

    • Corresponding Author InformationCorresponding author. Address for correspondence: Professor J.R. Attali, MD, Département Endocrinologie, CHU Jean Verdier, F-93143 Bondy, France

References 

  1. Unger RH , Grundy S . Hyperglycemia as an inducer as well as a consequences of impaired islet cell function an insulin resistance . Diabetologia . 1985;28:119–121
  2. Glasser B , Leibovich G , Nesher R , Hartling S , Binder C , Cerasi E . Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes . Acta Endocrinol . 1988;118:365–373
  3. Valensi P , Moura I , Le Magoarou M , Pariès J , Perret G , Attali JR . Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulindependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment . Diabetes Metab . 1997;23:51–57
  4. Lormeau B , Aurousseau MH , Valensi P , Pariès J , Attali JR . Hyperinsulinemia and hypofibrinolysis: effects of short-term optimized glycemic control with continuous-insuiln infusion in type 2 diabetic patients . Metabolism . 1997;46:1074–1079
  5. Albertini JP , Valensi P , Lormeau B , Aurousseau MH , Ferrière F , Attali JR , et al.   Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM . Diabetes Care . 1998;21:1008–1013
  6. Ilkova H , Glaser B , Tunckale A , Bayriacik N , Cerasi E . Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment . Diabetes Care . 1997;20:1353–1356
  7. Sunwin P , Soo Bong Choi  . Induction of long-term normoglycemia without medication in Korean type 2 diabetes patients after continuous subcutaneous insuiln infusion therapy . Diabetes Metab Res Rev . 2003;19:124–130
  8. Hammond P . Continuous subcutaneous insulin infusion: shortterm benefits apparent, long-term benefits speculative . Br J Diabetes Vasc Dis . 2004;4:104–108
  9. Kirk SE . Insulin pump therapy for type 2 diabetes . Current Diabetes Reports . 2003;3:373–377
  10. Edelman SV . Pumps and type 2 diabetes . Diabetes Forecast . June 2002;

PII: S0168-8227(06)70012-2

doi: 10.1016/S0168-8227(06)70012-2

Diabetes Research and Clinical Practice
Volume 74 , Pages S116-S118 , December 2006

Article Tools